HYPERION DEFI, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
HYPERION DEFI, INC. (HYPD) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $1.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2026-08-13
- HYPERION DEFI, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-06-30 was $1.55M.
- HYPERION DEFI, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-03-31 was $1.69M.
- HYPERION DEFI, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2025 was $5.79M, a 2220.47% increase from fiscal 2024.
- HYPERION DEFI, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2024 was $249.33K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2026-06-30 | $1.55M 10-Q · filed 2026-08-13 | $3.24M derived: sum of 2 quarters · filed 2026-08-13 | |
| 2026-03-31 | $1.69M 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $5.79M 10-K · filed 2026-03-30 | ||
| 2024-12-31 | $249.33K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |